Clinical utility of molecular probes in lymphoproliferative disorders

Research output: Contribution to journalArticlepeer-review


The use of molecular probes to diagnose and evaluate human malignancies has been most prominent in the disease category of malignant lymphoma. While this technology is daunting, it has gained rapid entry into the laboratories of both academic and community hospitals. This is because the molecular analysis of genetic changes in human disease, especially the human lymphomas, contributes to many facets of care including aiding the diagnosis, providing prognosis and helping to monitor the disease process. This review aims to highlight both the current routinely available technology and its practical applications in human lymphoma.

Original languageEnglish (US)
Pages (from-to)81-88
Number of pages8
JournalBlood Reviews
Issue number2
StatePublished - Jun 1996

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'Clinical utility of molecular probes in lymphoproliferative disorders'. Together they form a unique fingerprint.

Cite this